HEMAY PHARM (00054.HK): Global Offering of 55.21m H Shares at Up to HK$18.90
NewTimeSpace News: On 30 October 2026, Ganzhou Hemay Pharmaceutical Co., Ltd. (stock code: 0054) published its global offering announcement for 55,210,000 H shares (subject to the over-allotment option) at a maximum price of HK$18.90 per H share, plus a 1.0% brokerage fee and transaction levies; the offer price may be lowered, with HK$14.00 per share applying if set at the minimum permitted price.
The Hong Kong offer comprises 5,521,000 shares (subject to adjustment) and the international offer 49,689,000 shares (subject to adjustment and the over-allotment option). At the maximum price, gross proceeds would be about HK$1,043 million before expenses, or about HK$773 million at the minimum price of HK$14.00. The H shares have a nominal value of RMB1.0 each.
Assuming the global offering becomes unconditional by 8:00 am on 9 November 2026, the H shares are expected to begin trading on the Stock Exchange at 9:00 am the same day, in board lots of 100 H shares under stock code 0054.
- HEMAY PHARMA：passed HKEX listing hearing, Mufemilast approved for Ps
- HK Stock Connect Insight | JS GLOBAL LIFESTYLE (01691.HK) Rebounds Over 13% Since Removal; Controlling Shareholder Plans to Pledge 52.87% Stake on October 16
- YZYBIO-B (02496.HK): Proposes Issuing 35.59 Million Domestic Shares to Three Directors at RMB 2.43 Each, Raising about RMB 83 Million; Whitewash Waiver Sought and Trading to Resume
- GLOBAL BIO-CHEM (00809.HK): Boiler Renovation Project Completed and Commissioned; Coenzyme Q10 Project Civil Works Started at Dehui Base
- CNGR Advanced Material (02579.HK): Proposed Change in Use of Proceeds from Global H‑Share Offering
